{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:20:38Z","timestamp":1793132438881,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada i Rozwoju","doi-asserted-by":"publisher","award":["WND-POIG.01.01.02-00-007\/08"],"award-info":[{"award-number":["WND-POIG.01.01.02-00-007\/08"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada i Rozwoju","doi-asserted-by":"publisher","award":["PBS2\/A7\/14\/2014"],"award-info":[{"award-number":["PBS2\/A7\/14\/2014"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["097383"],"award-info":[{"award-number":["097383"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12985-016-0599-y","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T01:21:31Z","timestamp":1472174491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens"],"prefix":"10.1186","volume":"13","author":[{"given":"Anna","family":"Stachyra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Redkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Protasiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"G\u00f3ra-Sochacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Kudla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-2924","authenticated-orcid":false,"given":"Agnieszka","family":"Sirko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"key":"599_CR1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/CMR.00097-12","volume":"26","author":"SS Wong","year":"2013","unstructured":"Wong SS, Webby RJ. Traditional and new influenza vaccines. Clin Microbiol Rev. 2013;26:476\u201392.","journal-title":"Clin Microbiol Rev"},{"key":"599_CR2","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","volume":"21","author":"C Gerdil","year":"2003","unstructured":"Gerdil C. The annual production cycle for influenza vaccine. Vaccine. 2003;21:1776\u20139.","journal-title":"Vaccine"},{"key":"599_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.11599\/germs.2013.1034","volume":"3","author":"KH Khan","year":"2013","unstructured":"Khan KH. DNA vaccines: roles against diseases. Germs. 2013;3:26\u201335.","journal-title":"Germs"},{"key":"599_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5501\/wjv.v4.i3.156","volume":"4","author":"M Trovato","year":"2015","unstructured":"Trovato M, Berardinis PD. Novel antigen delivery systems. World J Virol. 2015;4:156\u201368.","journal-title":"World J Virol"},{"key":"599_CR5","doi-asserted-by":"crossref","unstructured":"Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, et al. Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost. Contemp Clin Trials. 2015;44:112-18.","DOI":"10.1016\/j.cct.2015.08.006"},{"key":"599_CR6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(14)62385-0","volume":"385","author":"H Kibuuka","year":"2015","unstructured":"Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB, Costner P, Sitar S, Glover D, Hu Z, et al. Safety and immunogenicity of ebola virus and marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet. 2015;385:1545\u201354.","journal-title":"Lancet"},{"key":"599_CR7","first-page":"515","volume":"61","author":"A Stachyra","year":"2014","unstructured":"Stachyra A, G\u00f3ra-Sochacka A, Sirko A. DNA vaccines against influenza. Acta Biochim Pol. 2014;61:515\u201322.","journal-title":"Acta Biochim Pol"},{"key":"599_CR8","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1128\/JVI.01065-06","volume":"80","author":"S Wang","year":"2006","unstructured":"Wang S, Taaffe J, Parker C, Solorzano A, Cao H, Garcia-Sastre A, Lu S. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza a viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol. 2006;80:11628\u201337.","journal-title":"J Virol"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.vaccine.2010.02.090","volume":"28","author":"M Tenbusch","year":"2010","unstructured":"Tenbusch M, Grunwald T, Niezold T, Storcksdieck Genannt Bonsmann M, Hannaman D, Norley S, Uberla K. Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice. Vaccine. 2010;28:3273\u20137.","journal-title":"Vaccine"},{"key":"599_CR10","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.vaccine.2012.03.026","volume":"30","author":"A Ault","year":"2012","unstructured":"Ault A, Zajac AM, Kong WP, Gorres JP, Royals M, Wei CJ, Bao S, Yang ZY, Reedy SE, Sturgill TL, et al. Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies. Vaccine. 2012;30:3965\u201374.","journal-title":"Vaccine"},{"key":"599_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virusres.2013.05.009","volume":"178","author":"S Sonnberg","year":"2013","unstructured":"Sonnberg S, Webby RJ, Webster RG. Natural history of highly pathogenic avian influenza H5N1. Virus Res. 2013;178:63\u201377.","journal-title":"Virus Res"},{"key":"599_CR12","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/nm1141","volume":"10","author":"P Palese","year":"2004","unstructured":"Palese P. Influenza: old and new threats. Nat Med. 2004;10:S82\u20137.","journal-title":"Nat Med"},{"key":"599_CR13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.antiviral.2007.03.009","volume":"75","author":"Y Jiang","year":"2007","unstructured":"Jiang Y, Yu K, Zhang H, Zhang P, Li C, Tian G, Li Y, Wang X, Ge J, Bu Z, Chen H. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res. 2007;75:234\u201341.","journal-title":"Antiviral Res"},{"key":"599_CR14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1637\/10150-040812-ResNote.1","volume":"56","author":"JP Li","year":"2012","unstructured":"Li JP, Jiang YP, Zhao SC, Chang XF, Liu JX, Zeng XY, Li YB, Chen HL. Protective efficacy of an H5N1 DNA vaccine against challenge with a lethal H5N1 virus in quail. Avian Dis. 2012;56:937\u20139.","journal-title":"Avian Dis"},{"key":"599_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jviromet.2011.02.008","volume":"173","author":"S Shan","year":"2011","unstructured":"Shan S, Jiang Y, Bu Z, Ellis T, Zeng X, Edwards J, Tian G, Li Y, Ge J, Chen H, Fenwick S. Strategies for improving the efficacy of a H6 subtype avian influenza DNA vaccine in chickens. J Virol Methods. 2011;173:220\u20136.","journal-title":"J Virol Methods"},{"key":"599_CR16","doi-asserted-by":"crossref","first-page":"e2432","DOI":"10.1371\/journal.pone.0002432","volume":"3","author":"S Rao","year":"2008","unstructured":"Rao S, Kong WP, Wei CJ, Yang ZY, Nason M, Styles D, DeTolla LJ, Panda A, Sorrell EM, Song H, et al. Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS One. 2008;3:e2432.","journal-title":"PLoS One"},{"key":"599_CR17","doi-asserted-by":"crossref","first-page":"13538","DOI":"10.1073\/pnas.0806901105","volume":"105","author":"MW Chen","year":"2008","unstructured":"Chen MW, Cheng TJ, Huang Y, Jan JT, Ma SH, Yu AL, Wong CH, Ho DD. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A. 2008;105:13538\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"599_CR18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbrc.2004.11.134","volume":"327","author":"RM Goetz","year":"2005","unstructured":"Goetz RM, Fuglsang A. Correlation of codon bias measures with mRNA levels: analysis of transcriptome data from escherichia coli. Biochem Biophys Res Commun. 2005;327:4\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"599_CR19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature02535","volume":"429","author":"JS Han","year":"2004","unstructured":"Han JS, Boeke JD. A highly active synthetic mammalian retrotransposon. Nature. 2004;429:314\u20138.","journal-title":"Nature"},{"key":"599_CR20","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1371\/journal.pbio.0040180","volume":"4","author":"G Kudla","year":"2006","unstructured":"Kudla G, Lipinski L, Caffin F, Helwak A, Zylicz M. High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol. 2006;4:e180.","journal-title":"PLoS Biol"},{"key":"599_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2003.11.021","volume":"319","author":"KL Nguyen","year":"2004","unstructured":"Nguyen KL, Llano M, Akari H, Miyagi E, Poeschla EM, Strebel K, Bour S. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology. 2004;319:163\u201375.","journal-title":"Virology"},{"key":"599_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trivac.2014.02.002","volume":"3","author":"A Stachyra","year":"2014","unstructured":"Stachyra A, G\u00f3ra-Sochacka A, Sawicka R, Florys K, S\u0105czy\u0144ska V, Olszewska M, Piku\u0142a A, \u015amietanka K, Minta Z, Szewczyk B, et al. Highly immunogenic prime\u2013boost DNA vaccination protects chickens against challenge with homologous and heterologous H5N1 virus. Trials Vaccinology. 2014;3:40\u20136.","journal-title":"Trials Vaccinology"},{"key":"599_CR23","first-page":"593","volume":"61","author":"A Stachyra","year":"2014","unstructured":"Stachyra A, Gora-Sochacka A, Zagorski-Ostoja W, Krol E, Sirko A. Antibody response to DNA vaccine against H5N1 avian influenza virus in broilers immunized according to three schedules. Acta Biochim Pol. 2014;61:593\u20136.","journal-title":"Acta Biochim Pol"},{"key":"599_CR24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4236\/aim.2016.64030","volume":"6","author":"S Shan","year":"2016","unstructured":"Shan S, Ellis T, Edwards J, Fenwick S, Robertson I. Comparison of five expression vectors for the Ha gene in constructing a DNA vaccine for H6N2 influenza virus in chickens. Adv Microbiol. 2016;6:310\u20139.","journal-title":"Adv Microbiol"},{"key":"599_CR25","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.4049\/jimmunol.161.10.5594","volume":"161","author":"M Uchijima","year":"1998","unstructured":"Uchijima M, Yoshida A, Nagata T, Koide Y. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol. 1998;161:5594\u20139.","journal-title":"J Immunol"},{"key":"599_CR26","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1128\/JVI.75.22.10991-11001.2001","volume":"75","author":"L Deml","year":"2001","unstructured":"Deml L, Bojak A, Steck S, Graf M, Wild J, Schirmbeck R, Wolf H, Wagner R. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol. 2001;75:10991\u20131001.","journal-title":"J Virol"},{"key":"599_CR27","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1099\/vir.0.013730-0","volume":"90","author":"CS Siegismund","year":"2009","unstructured":"Siegismund CS, Hohn O, Kurth R, Norley S. Enhanced T- and B-cell responses to simian immunodeficiency virus (SIV)agm, SIVmac and human immunodeficiency virus type 1 Gag DNA immunization and identification of novel T-cell epitopes in mice via codon optimization. J Gen Virol. 2009;90:2513\u20138.","journal-title":"J Gen Virol"},{"key":"599_CR28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123\u201332.","journal-title":"Nat Immunol"},{"key":"599_CR29","first-page":"31","volume":"1","author":"PJ Conlon","year":"1989","unstructured":"Conlon PJ, Tyler S, Grabstein KH, Morrissey P. Interleukin-4 (B-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals. Biotechnol Ther. 1989;1:31\u201341.","journal-title":"Biotechnol Ther"},{"key":"599_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1297-9686-45-9","volume":"45","author":"YS Rao","year":"2013","unstructured":"Rao YS, Chai XW, Wang ZF, Nie QH, Zhang XQ. Impact of GC content on gene expression pattern in chicken. Genet Sel Evol. 2013;45:9.","journal-title":"Genet Sel Evol"},{"key":"599_CR31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","volume":"72","author":"S Andre","year":"1998","unstructured":"Andre S, Seed B, Eberle J, Schraut W, Bultmann A, Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol. 1998;72:1497\u2013503.","journal-title":"J Virol"},{"key":"599_CR32","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.70.7.4646-4654.1996","volume":"70","author":"S Zolotukhin","year":"1996","unstructured":"Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N. A \u201chumanized\u201d green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol. 1996;70:4646\u201354.","journal-title":"J Virol"},{"key":"599_CR33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3382\/ps\/pev015","volume":"94","author":"M Buza\u0142a","year":"2015","unstructured":"Buza\u0142a M, Janicki B, Czarnecki R. Consequences of different growth rates in broiler breeder and layer hens on embryogenesis, metabolism and metabolic rate: a review. Poult Sci. 2015;94:728\u201333.","journal-title":"Poult Sci"},{"key":"599_CR34","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3382\/ps\/pev127","volume":"94","author":"PJ Groves","year":"2015","unstructured":"Groves PJ, Sharpe SM, Cox JM. Response of layer and broiler strain chickens to parenteral administration of a live salmonella typhimurium vaccine. Poult Sci. 2015;94:1512\u201320.","journal-title":"Poult Sci"},{"key":"599_CR35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/03079450903183645","volume":"38","author":"RA Penha Filho","year":"2009","unstructured":"Penha Filho RA, de Paiva JB, Arguello YM, da Silva MD, Gardin Y, Resende F, Berchieri Junior AB, Sesti L. Efficacy of several vaccination programmes in commercial layer and broiler breeder hens against experimental challenge with salmonella enterica serovar enteritidis. Avian Pathol. 2009;38:367\u201375.","journal-title":"Avian Pathol"},{"key":"599_CR36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-2427(02)00169-1","volume":"89","author":"ME Koenen","year":"2002","unstructured":"Koenen ME, Boonstra-Blom AG, Jeurissen SH. Immunological differences between layer- and broiler-type chickens. Vet Immunol Immunopathol. 2002;89:47\u201356.","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-016-0599-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T21:13:42Z","timestamp":1692479622000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-016-0599-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/s12985-016-0599-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,26]]},"article-number":"143"}}